ArticleInternational journal of bioprinting2023
Wall shear stress during impingement at the building platform can exceed nozzle wall shear stress in microvalve-based bioprinting.
Article in International journal of bioprinting, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 13 citations in OpenAlex.
- Effect of Hydrodynamic Shear Stress on Algal Cell Fate in 3D Extrusion Bioprinting.Advanced engineering materials · 2025Article
- Effects of Coaxial Nozzle's Inner Nozzle Diameter on Filament Strength and Gelation in Extrusion-Based 3D Printing with In Situ Ionic Crosslinking.Biomimetics (Basel, Switzerland) · 2024Article
- 3D Bioprinting of Microbial-based Living Materials for Advanced Energy and Environmental Applications.Chem & bio engineering · 2024Review
- Transformative Materials to Create 3D Functional Human Tissue Models In Vitro in a Reproducible Manner.Advanced healthcare materials · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is well known that in microvalve-based bioprinting, the cells are subjected to wall shear stress, which can negatively affect their viability rate. We hypothesized that the wall shear stress during impingement at the building platform, hitherto not considered in microvalve-based bioprinting, can be even more critical for the processed cells than the wall shear stress inside the nozzle. To test our hypothesis, we used fluid mechanics numerical simulation based on finite volume method. In addition, viability of two functionally different cell types, HaCaT cell line and primary human umbilical vein endothelial cells (HUVECs), embedded in the cellladen hydrogel was assessed after bioprinting. Simulation results revealed that at low upstream pressure the kinetic energy was not sufficient to overcome the interfacial force for droplet formation and detachment. Oppositely, at relatively mid upstream pressure, a droplet and a ligament were formed, whereas at higher upstream pressure, a jet was formed between nozzle and platform. In the case of jet formation, the shear stress during impingement can exceed the wall shear stress in the nozzle. The amplitude of impingement shear stress depended on nozzle-to- platform distance. This was confirmed by evaluating cell viability which revealed an increase of up to 10% when increasing the nozzle-to-platform distance from 0.3 to 3 mm. In conclusion, the impingement-related shear stress can exceed the wall shear stress in the nozzle in microvalve-based bioprinting. However, this critical issue can be successfully addressed by adapting the distance between the nozzle and the building platform. Altogether, our results highlight impingement-related shear stress as another essential parameter to consider in devising bioprinting strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.